ARCHIVES

Jerome Yates Named VP For Research At ACS

This article is from The Cancer Letter archive.

Vol. 28 No. 06 | February 8, 2002

Download PDF Visit The Full Archive

Related Articles

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999

Committee Drafts QRA Definition

November 19, 1982

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011